These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36159109)

  • 1. Elevated Serum Levels of Interleukin-15 in Pemphigus Vulgaris Patients: a Potential Therapeutic Target.
    Kheirodin M; Tehranchinia Z; Ketabi Y; Tavakolpour S; Dadkhahfar S; Faghankhani M; Vahidnezhad H; Mozafari N
    Dermatol Pract Concept; 2022 Jul; 12(3):e2022118. PubMed ID: 36159109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The elevated level of osteopontin in patients with pemphigus vulgaris: A cytokine-like protein with a therapeutic potential.
    Ketabi Y; Nasiri S; Kheirodin M; Tavakolpour S; Mozafari N
    Dermatol Ther; 2019 Jul; 32(4):e12973. PubMed ID: 31136685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between salivary and serum anti-desmoglein 1 and 3 antibody titres using ELISA and between anti-desmoglein levels and disease severity in pemphigus vulgaris.
    De D; Khullar G; Handa S; Joshi N; Saikia B; Minz RW
    Clin Exp Dermatol; 2017 Aug; 42(6):648-650. PubMed ID: 28543318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
    Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies.
    Mohebi F; Tavakolpour S; Teimourpour A; Toosi R; Mahmoudi H; Balighi K; Ghandi N; Ghiasi M; Nourmohammadpour P; Lajevardi V; Abedini R; Azizpour A; Nasimi M; Daneshpazhooh M
    BMC Dermatol; 2020 Oct; 20(1):13. PubMed ID: 33129291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigus disease activity measurements: pemphigus disease area index, autoimmune bullous skin disorder intensity score, and pemphigus vulgaris activity score.
    Rahbar Z; Daneshpazhooh M; Mirshams-Shahshahani M; Esmaili N; Heidari K; Aghazadeh N; Hejazi P; Ghajarzadeh M; Chams-Davatchi C
    JAMA Dermatol; 2014 Mar; 150(3):266-72. PubMed ID: 24429657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of T(H)1/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-Pemphigus vulgaris.
    Satyam A; Khandpur S; Sharma VK; Sharma A
    Immunol Invest; 2009; 38(6):498-509. PubMed ID: 19811408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary and Serum Anti-Desmoglein 1 and 3 ELISA and Indirect Immunofluorescence in Pemphigus Vulgaris: Correlations with Serum ELISA, Indirect Immunofluorescence and Disease Severity.
    Koopai M; Mortazavi H; Khatami A; Khodashenas Z
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):91-99. PubMed ID: 29989863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
    Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
    Sharma VK; Prasad HR; Khandpur S; Kumar A
    Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool.
    Lenz P; Amagai M; Volc-Platzer B; Stingl G; Kirnbauer R
    Arch Dermatol; 1999 Feb; 135(2):143-8. PubMed ID: 10052398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
    Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
    Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, but Not Chronic Patients With Inactive Disease Compared to Healthy Controls.
    Shahbazian P; Izad M; Daneshpazhooh M; Mortazavi H; Salehi Z; Behruzifar S; Tavakolpour S; Azizpour A
    Dermatol Pract Concept; 2021 Mar; 11(2):e2021035. PubMed ID: 33954018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin autoantibody profile in patients with pemphigus vulgaris.
    Oliveira ME; Culton DA; Prisayanh P; Qaqish BF; Diaz LA
    Br J Dermatol; 2013 Oct; 169(4):812-8. PubMed ID: 23725016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease progression and response to therapy in pemphigus based on a registry.
    Pieper J; Pollmann R; Eming R; Greene B; Hahmann M; Hertl M
    J Dtsch Dermatol Ges; 2022 Apr; 20(4):461-467. PubMed ID: 35446493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
    Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil.
    Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML
    Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1.
    Lin MS; Swartz SJ; Lopez A; Ding X; Fairley JA; Diaz LA
    J Invest Dermatol; 1997 Dec; 109(6):734-7. PubMed ID: 9406813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.